Diabetes Mellitus Stocks List

Diabetes Mellitus Stocks Recent News

Date Stock Title
May 3 CORT Corcept Therapeutics First Quarter 2024 Earnings: Beats Expectations
May 3 HALO How Novo-Catalent Deal Affects Halozyme (HALO)?
May 2 PODD Insulet (PODD) Rises Higher Than Market: Key Facts
May 2 CORT The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts
May 2 CORT Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates
May 2 CORT Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
May 2 PODD Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
May 2 SENS Senseonics Holdings, Inc. to Participate in Upcoming Conferences
May 2 CORT Q1 2024 Corcept Therapeutics Inc Earnings Call
May 2 CORT Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
May 2 CORT Corcept Therapeutics Incorporated (CORT) Q1 2024 Earnings Call Transcript
May 1 CORT Corcept Therapeutics Inc (CORT) Outperforms Analyst Estimates in Q1 2024
May 1 CORT Corcept Therapeutics GAAP EPS of $0.25 beats by $0.03, revenue of $146.81M beats by $5.61M
May 1 CORT Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
May 1 DXCM Can DexCom, Inc.'s (NASDAQ:DXCM) ROE Continue To Surpass The Industry Average?
May 1 SENS Senseonics gets FDA clearance to pair CGM implant with insulin pumps
Apr 30 CORT Corcept Therapeutics Q1 2024 Earnings Preview
Apr 30 SENS Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
Apr 30 DXCM Dexcom Stock Continues To Post Very Healthy Profits, Returns
Apr 30 DXCM Here is Why Growth Investors Should Buy DexCom (DXCM) Now
Diabetes Mellitus

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags